ketorolac tromethamine has been researched along with Miosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joo, CK; Jun, JH; Lim, SA; Yoo, YS | 1 |
| Earl, M; Heier, J; Hunkeler, JD; Kenyon, KR; Silverstein, S; Wittpenn, JR | 1 |
| Kim, A; Stark, WJ | 1 |
| Apple, DJ; Solomon, KD; Stewart, JA; Turkalj, JW; Whiteside, SB | 1 |
| Cheetham, JK; Grosserode, R; Rosenthal, A; Stewart, R | 1 |
| Donnenfeld, E; Schwiegerling, J; Siekert, RW; Snyder, RW; Thompson, P | 1 |
4 trial(s) available for ketorolac tromethamine and Miosis
| Article | Year |
|---|---|
A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Contrast Sensitivity; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Ketorolac Tromethamine; Lens Implantation, Intraocular; Macular Edema; Male; Miosis; Phacoemulsification; Prednisolone; Premedication; Prospective Studies; Risk Factors; Treatment Outcome; Visual Acuity | 2008 |
Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Female; Flurbiprofen; Humans; Ketorolac Tromethamine; Lenses, Intraocular; Male; Middle Aged; Miosis; Ophthalmic Solutions; Phacoemulsification; Prospective Studies; Pupil; Tolmetin; Treatment Outcome; Tromethamine | 1997 |
Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cataract Extraction; Double-Blind Method; Female; Humans; Ketorolac Tromethamine; Male; Middle Aged; Miosis; Ophthalmic Solutions; Postoperative Complications; Tolmetin; Tromethamine | 1999 |
Acular as a single agent for use as an antimiotic and anti-inflammatory in cataract surgery.
Topics: Anterior Chamber; Anti-Inflammatory Agents, Non-Steroidal; Cataract Extraction; Cell Count; Drug Administration Schedule; Drug Therapy, Combination; Endophthalmitis; Flurbiprofen; Glucocorticoids; Humans; Ketorolac Tromethamine; Miosis; Ophthalmic Solutions; Postoperative Period; Prednisolone; Preoperative Care; Safety | 2000 |
2 other study(ies) available for ketorolac tromethamine and Miosis
| Article | Year |
|---|---|
Effects of topical ketorolac tromethamine 0.45% on intraoperative miosis and prostaglandin E
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cataract Extraction; Humans; Ketorolac Tromethamine; Lasers; Miosis; Prospective Studies; Prostaglandins E; Pupil | 2017 |
Are topical NSAIDs needed for routine cataract surgery?
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Glucocorticoids; Humans; Ketorolac Tromethamine; Lens Implantation, Intraocular; Macular Edema; Miosis; Phacoemulsification; Postoperative Complications; Prednisolone | 2008 |